The biotechnology company will tap into Catalent’s expertise in induced pluripotent stem cells and advanced cell-therapy manufacturing
The conflict is also triggering a widening public health emergency
Nearly 12 million people are estimated to be living with glaucoma, making the country one of the worst affected globally
The Hydrus Microstent stands out as the first and only MIGS device backed by five-year clinical outcomes
ABBV-295 produced clinically meaningful, dose-dependent weight loss over 12–13 weeks
AA, a chronic immune disease, can cause extensive and unpredictable hair loss
Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models
Semaglutide—a glucagon?like peptide?1 receptor agonist (GLP-1RA) sold as Ozempic and Rybelsus for type 2 diabetes, and Wegovy for weight management and cardiovascular risk reduction
_Limited_256_384.jpg)
Subscribe To Our Newsletter & Stay Updated
